.

06 August 2021

Le Temps is reporting about CHF 7.2 million of seed funding raised for the development of RocketVax’s SARS-CoV-2 vaccine

“Founded in 2020, Basel-based company RocketVax has just secured funding to launch the pre-clinical phase of its Covid-19 vaccine development”.

To read the full article published by Le Temps, click on the file below.

LeTemps_2021_08_05

Source: Le Temps

Share

19 August 2021

L’Avenir: “Two new vaccines are expected in late 2021”

“Two new vaccines against COVID-19, using the recombinant protein technique, could be added to the vaccine range by the end of the year. One of them will be a Swiss vaccine: RocketVax.” To read the full interview with Dr. Vladimir Cmiljanovic, CEO of RocketVax, click on the document below. L’Avenir_2021_08_06 Source: L’Avenir Share

23 July 2021

BZ Basel: “One step closer to new vaccine: human testing next year”

“RocketVax, a Basel-based company, has cleared another hurdle in the production of its new vaccine. It should protect longer and better against the coronavirus, as well as be able to be delivered all over the world.” BZ Basel is reporting about RocketVax’s SARS-CoV-2 vaccine. To read the full article, open the document below: BZ_Basel_20210716 Source: […]

29 June 2021

Bajour: “Big Pharma brings the power, startups provide the creativity”

Bajour is reporting about the creativity and potential of startup pharma companies. Among others, they presented the RocketVax project, the second-generation SARS-CoV-2 vaccine, led by Prof. Dr. Thomas Klimkait. To read the full article, click on the link below: bajour.pdf Source: bajour.ch Share

23 June 2021

“New vaccine should protect longer” – BZ Basel is reporting about RocketVax’s SARS-CoV-2 vaccine

The University Hospital Basel (USB), the University of Basel, and the Swiss Tropical and Public Health Institute (Swiss TPH) are entering into a research collaboration with the startup company RocketVax. The goal is to develop a next-generation vaccine against Covid-19 that will provide better protection against viral mutants and elicit a longer-term immune response. The […]

22 June 2021

BaZ: “Basel government approves one million for coronavirus vaccine”

“The Basel government is getting involved in the development of another vaccine against Covid-19. The government approved a CHF 1 million grant from the local development fund to support the preclinical development of a vaccine from the Basel-based start-up RocketVax. RocketVax, founded in the summer of 2020 and headquartered in Basel, is a subsidiary of […]